Presentation is loading. Please wait.

Presentation is loading. Please wait.

Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)  Axel.

Published byÉmilien Pinard Modified over 6 years ago

Similar presentations

Presentation on theme: "Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)  Axel."— Presentation transcript:

1 Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)  Axel Le Cesne, Jean-Yves Blay, Binh Nguyen Bui, Olivier Bouché, Antoine Adenis, Julien Domont, Angela Cioffi, Isabelle Ray-Coquard, Nathalie Lassau, Sylvie Bonvalot, Alain Moussy, Jean-Pierre Kinet, Olivier Hermine  European Journal of Cancer  Volume 46, Issue 8, Pages (May 2010) DOI: /j.ejca Copyright © 2010 Elsevier Ltd Terms and Conditions

2 Fig. 1 Kaplan–Meier analyses of progression-free survival (A) and overall survival (B). European Journal of Cancer  , DOI: ( /j.ejca ) Copyright © 2010 Elsevier Ltd Terms and Conditions

Download ppt "Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)  Axel."

Similar presentations

Plantar Flexion as an Alternative to Treadmill Exercise for Evaluating Patients with Intermittent Claudication K. Yamamoto, T. Miyata, A. Onozuka, H. Koyama,

Plantar Flexion as an Alternative to Treadmill Exercise for Evaluating Patients with Intermittent Claudication K. Yamamoto, T. Miyata, A. Onozuka, H. Koyama,
Clinical leadership development in a pre-registration nursing curriculum: What the profession has to say about it Angela Brown, Patrick Crookes, Jan Dewing.

Clinical leadership development in a pre-registration nursing curriculum: What the profession has to say about it Angela Brown, Patrick Crookes, Jan Dewing.
Ola Wallengren, Ingvar Bosaeus, Kent Lundholm  Clinical Nutrition 

Ola Wallengren, Ingvar Bosaeus, Kent Lundholm  Clinical Nutrition 
Evaluation of survival across several treatment lines in metastatic colorectal cancer: Analysis of the FIRE-3 trial (AIO KRK0306)  D.P. Modest, I. Ricard,

Evaluation of survival across several treatment lines in metastatic colorectal cancer: Analysis of the FIRE-3 trial (AIO KRK0306)  D.P. Modest, I. Ricard,
Breast Cancer Advocacy across Europe through the work and development of EUROPA DONNA, the European Breast Cancer Coalition  M. Buchanan, S. Kyriakides,

Breast Cancer Advocacy across Europe through the work and development of EUROPA DONNA, the European Breast Cancer Coalition  M. Buchanan, S. Kyriakides,
Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one.

Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one.
European Journal of Cancer

European Journal of Cancer
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children.

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children.
Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell.

Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell.
Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phase.

Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phase.
Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma:

Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma:
European Journal of Cancer

European Journal of Cancer
Rare cancers of the head and neck area in Europe

Rare cancers of the head and neck area in Europe
Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype  Romain Micol, MD, MPH, PhD, Lilia Ben Slama, PhD, Felipe Suarez, MD,

Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype  Romain Micol, MD, MPH, PhD, Lilia Ben Slama, PhD, Felipe Suarez, MD,
Volume 80, Issue 3, Pages (March 2009)

Volume 80, Issue 3, Pages (March 2009)
Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit  Pim J. van Leeuwen, David Connolly, Anna.

Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit  Pim J. van Leeuwen, David Connolly, Anna.
Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1–3 brain metastases: Results.

Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1–3 brain metastases: Results.
Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating.

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating.
Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer  Philippe O. Gannon, Laurent Lessard, Louis-Mathieu.

Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer  Philippe O. Gannon, Laurent Lessard, Louis-Mathieu.
Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial)  M. Yoshida, K. Muro, A. Tsuji,

Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial)  M. Yoshida, K. Muro, A. Tsuji,

Similar presentations

Ads by Google